The Horizon Kinetics Medical ETF (the “Fund”) seeks long-term growth of capital. The Fund is an actively-managed exchange-traded fund (“ETF”) that will invest primarily in patented first line pharmaceuticals and biologics as these products tend to have high profit margins and significant barriers to entry. The Fund employs a long-term perspective, seeking to capture returns of both intrinsic valuation realization and scientific discovery.

فئة الأصول

Equity

الجهة المصدرة

Horizon Kinetics

موطن التسجيل

US

تاريخ التأسيس

26 يناير 2023

عدد الحيازات

32

ISIN

US53656G5633